Published 12:19 IST, July 2nd 2020
Pfizer, BioNTech experimental COVID-19 vaccine shows promise in early trial: Study
The American pharmaceutical giant Pfizer Inc. and the European biotechnology company BioNTech SE have conducted an experimental trial of a COVID-19 vaccine candidate and found it to be safe, well-tolerated, and capable of generating antibodies in the patients.
null | Image:
self
Advertisement
12:18 IST, July 2nd 2020